SIEM BIOMEDICALE
France FR-MF-000027494 Last updated 21 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 1
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
VisioSystem Ref VISIOSYSTEM-20C
What SIEM BIOMEDICALE makes
SIEM BIOMEDICALE manufactures the VisioSystem, a medical imaging device designed for diagnostic applications in clinical settings. This system is intended for capturing and analyzing visual data, likely supporting procedures such as endoscopy or other internal examinations.
The VisioSystem falls under EU Class IIa medical devices and is registered in the EU’s eudamed database. The company is based in France, adhering to European Union regulatory requirements for medical device compliance.
Frequently asked questions
What types of medical devices does SIEM BIOMEDICALE manufacture?
SIEM BIOMEDICALE manufactures the VisioSystem, a medical imaging device. This device is designed for diagnostic purposes in clinical environments, likely used for capturing and analyzing visual data during procedures such as endoscopy or other internal examinations. The focus is on supporting accurate and detailed imaging for medical assessments.
Where is SIEM BIOMEDICALE based, and what regulatory framework does it follow?
SIEM BIOMEDICALE is based in France. As a manufacturer of medical devices, it operates under the European Union’s regulatory requirements, ensuring compliance with EU medical device regulations. This includes adherence to standards that govern the design, production, and performance of its devices, such as the VisioSystem.
Which regulatory registries list SIEM BIOMEDICALE’s devices?
SIEM BIOMEDICALE’s devices, including the VisioSystem, are listed in the eudamed database. This is the official EU registry for medical devices, where manufacturers provide information about their products to ensure transparency and traceability within the European market.
How are SIEM BIOMEDICALE’s devices classified under EU regulations?
The VisioSystem from SIEM BIOMEDICALE is classified as a Class IIa medical device under EU regulations. This classification is determined by factors such as the device’s intended use, potential risks, and the level of intervention it involves. Class IIa devices require additional scrutiny compared to lower-risk categories but do not pose the highest risk levels seen in Class IIb or III devices.
Information
- Country
- France
- Address
- 781, chemin du Carreau de Lanes, Nîmes, France
- Website
- www.siem-biomedicale.com
- [email protected]
- Phone
- +33 4 66 23 12 88
- PRRC contact
- YOUSSEF LOURHZAL
- EUDAMED SRN
- FR-MF-000027494